Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting

– Announcing Invitae Generation™, a high-quality variant detection and classification platform – SAN FRANCISCO, March 5, 2024 /PRNewswire/ — Researchers from Invitae (OTC: NVTA), a leading medical genetics company, are showcasing their work next week at the 2024 American College of…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.